Shing M. Lee
Columbia University
9 Papers
4 Citations
Shing M. Lee is an academic researcher from Columbia University. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 4, co-authored 9 publications.
Chat about Author
Papers
Identifying Severe Adverse Event Clusters Using the National Cancer Institute's Common Terminology Criteria for Adverse Events.
TL;DR: This study proposed using the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) to identify adverse event clusters because the CTCAE data are collected as standard practice and can therefore be used when patient-reported outcomes are unavailable.
Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population.
Ying L. Liu,Anurag Saraf,Benjamin Peter Catanese,Shing M. Lee,Yuan Zhang,Eileen P. Connolly,Kevin Kalinsky +6 more
TL;DR: Obesity may negatively impact survival in breast cancer, with differences among tumor subtypes, and race/ethnicity was not associated with survival in any subtype, and there were no interactions with obesity on survival.
Invasive Lobular Breast Carcinoma: Pleomorphic Versus Classical Subtype, Associations and Prognosis
Ying L. Liu,Christine H. Choi,Shing M. Lee,Xiaobo Zhong,Hanina Hibshoosh,Kevin Kalinsky,Eileen P. Connolly +6 more
TL;DR: Invasive pleomorphic lobular carcinoma was initially associated with worse PFS, but this was attenuated after adjustment for cancer stage, and there were no differences in OS.
13
Using Delayed Toxicities to Re-evaluate Tolerability in Phase 2 Trials: A Case Example using Bortezomib.
TL;DR: In advanced stage patients enrolled in dose-finding trials, it is difficult to assess delayed toxicities because frequently patients discontinue after one or two cycles of treatment, but their data may be useful for evaluating long-term tolerability in phase 2 trials.
3
A comparison of nurses' and physicians' perception of cancer treatment burden based on reported adverse events.
TL;DR: Differences in the perception of burden of AEs can lead to different treatment decisions and symptom management strategies, and having provider consistency, training, or a collaborative approach in follow-up care between nurses and physicians is important to ensure continuity in care delivery.